Increasing Tysabri dosing interval may cut PML risk
Increasing Tysabri dosing interval may cut PML risk
Freedom from relapse was maintained in multiple sclerosis patients on Tysabri who received the infusion drug less frequently than the recommended 4-week interval, with lower risk of progressive multifocal leukoencephalopathy (PML), preliminary results from an ongoing analysis have indicated...... Read More - http://www.ms-uk.org/tysabri
MS-UK - http://www.ms-uk.org/
Re: Increasing Tysabri dosing interval may cut PML risk
Prior to any flag waving, please note that this is not a randomized double blind controlled trial...
Weinshenker commented that selection of patients for extended dosing, which was not random, might have involved "biases against committing more aggressive MS patients on the extended interval program, which might reduce the ability of the investigators to detect reduction in efficacy."
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2311 Views
-
Last post by NHE
-
- 6 Replies
- 6661 Views
-
Last post by ElliotB
-
- 0 Replies
- 3434 Views
-
Last post by NHE
-
- 0 Replies
- 1344 Views
-
Last post by NHE
-
- 1 Replies
- 1521 Views
-
Last post by NHE
-
- 11 Replies
- 3379 Views
-
Last post by NHE
-
- 1 Replies
- 1027 Views
-
Last post by NHE
-
- 0 Replies
- 3162 Views
-
Last post by NHE
-
- 0 Replies
- 1400 Views
-
Last post by NHE